Owens & Minor, Inc. (NYSE:OMI – Get Free Report) was down 5.4% during trading on Monday . The stock traded as low as $16.03 and last traded at $16.05. Approximately 392,925 shares traded hands during mid-day trading, a decline of 45% from the average daily volume of 708,673 shares. The stock had previously closed at $16.97.
Analysts Set New Price Targets
Several research analysts have commented on OMI shares. TheStreet upgraded shares of Owens & Minor from a “d+” rating to a “c-” rating in a research report on Monday, March 4th. StockNews.com cut shares of Owens & Minor from a “buy” rating to a “hold” rating in a research report on Thursday, May 23rd. Citigroup upped their price target on shares of Owens & Minor from $24.00 to $28.00 and gave the stock a “neutral” rating in a research note on Tuesday, April 30th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Owens & Minor in a research note on Monday, February 26th. Finally, SVB Leerink started coverage on shares of Owens & Minor in a research note on Monday, February 26th. They issued a “market perform” rating and a $24.00 price target for the company. One analyst has rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $23.29.
Owens & Minor Trading Down 4.7 %
The firm has a market capitalization of $1.24 billion, a price-to-earnings ratio of -31.71, a price-to-earnings-growth ratio of 0.55 and a beta of 0.33. The firm’s 50 day moving average is $19.69 and its 200 day moving average is $21.48. The company has a quick ratio of 0.56, a current ratio of 1.16 and a debt-to-equity ratio of 2.17.
Owens & Minor (NYSE:OMI – Get Free Report) last released its earnings results on Friday, May 3rd. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.17 by $0.02. Owens & Minor had a negative net margin of 0.37% and a positive return on equity of 12.97%. The business had revenue of $2.61 billion during the quarter, compared to analyst estimates of $2.61 billion. During the same period in the prior year, the business earned $0.05 earnings per share. The business’s quarterly revenue was up 3.6% on a year-over-year basis. Equities analysts forecast that Owens & Minor, Inc. will post 1.53 earnings per share for the current year.
Insider Activity at Owens & Minor
In related news, Director Mark A. Beck sold 9,344 shares of the company’s stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $17.25, for a total value of $161,184.00. Following the completion of the sale, the director now owns 11,154 shares in the company, valued at approximately $192,406.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, Director Mark A. Beck sold 9,344 shares of the company’s stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $17.25, for a total value of $161,184.00. Following the completion of the sale, the director now owns 11,154 shares in the company, valued at approximately $192,406.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Snehashish Sarkar sold 9,980 shares of the company’s stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $17.32, for a total transaction of $172,853.60. Following the completion of the sale, the executive vice president now owns 59,137 shares of the company’s stock, valued at approximately $1,024,252.84. The disclosure for this sale can be found here. Insiders sold a total of 36,923 shares of company stock valued at $686,911 over the last ninety days. Insiders own 3.59% of the company’s stock.
Institutional Investors Weigh In On Owens & Minor
Hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in Owens & Minor by 1.9% in the 1st quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company’s stock valued at $242,459,000 after buying an additional 162,182 shares during the period. Deerfield Management Company L.P. Series C increased its stake in Owens & Minor by 35.6% in the 3rd quarter. Deerfield Management Company L.P. Series C now owns 6,435,000 shares of the company’s stock valued at $103,990,000 after buying an additional 1,690,000 shares during the period. Dimensional Fund Advisors LP increased its stake in Owens & Minor by 8.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,210,991 shares of the company’s stock valued at $81,148,000 after buying an additional 327,002 shares during the period. Invesco Ltd. increased its stake in Owens & Minor by 12.0% in the 3rd quarter. Invesco Ltd. now owns 1,081,460 shares of the company’s stock valued at $17,476,000 after buying an additional 115,995 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in Owens & Minor by 4.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 825,142 shares of the company’s stock valued at $15,900,000 after buying an additional 38,393 shares during the period. Hedge funds and other institutional investors own 98.04% of the company’s stock.
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.